相关实验视频
Updated: Jul 10, 2026

06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
骨髓动员和血管内皮生长因子-2基因治疗在心肌缺血中的协同效应
Atsuhiko Kawamoto1, Toshinori Murayama, Kengo Kusano
1Division of Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA.
Circulation
|September 1, 2004
概括
结合细胞因子诱导的内皮原生细胞动员与血管内皮生长因子-2 (VEGF-2) 基因疗法,显著改善了心肌缺血的结果. 这种组合增强了骨髓细胞融入受损的心脏组织的功能.
科学领域:
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
- 基因治疗 基因治疗
背景情况:
- 慢性心肌缺血是一个重大的临床挑战.
- 目前的治疗策略在恢复心脏功能方面存在局限性.
- 研究新的组合疗法对于提高治疗疗效至关重要.
研究的目的:
- 评估结合血管性基因疗法与细胞因子诱导的内皮原生细胞动员治疗慢性心肌缺血症的协同效应.
- 为了确定这种组合治疗是否优于单个策略.
主要方法:
- 使用慢性心肌缺血的猪模型和急性心肌梗塞的小鼠模型.
- 采用心脏内血管内皮生长因子-2 (VEGF-2) 基因转移和皮下细胞因子 (CK) 注射.
- 在小鼠身上使用骨髓移植来追踪细胞融入心肌的过程.
主要成果:
- 与单一疗法相比,组合疗法在猪模型中的输液和功能表现出更好的改善.
- 在小鼠模型中,联合方法显著增加了骨髓衍生细胞的纳入新血管结构.
- 细胞因子诱导的动员增强了骨髓衍生的祖先的招募和/或保留.
结论:
- 细胞因子诱导的内皮原生细胞动员增强了肌心缺血的VEGF-2基因疗法.
- 这种组合策略增强了骨髓细胞的融入到缺血性心肌中,促进了组织修复.
相关概念视频
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

